[QUOTE=Slam dunk;385800]They sounded positive on the conf call. They said China/Sth Korea/Hong Kong were very strong, although acknowledged Aus/UK were tough. Northern hemisphere winter and holidays such as Chinese new year make for a stronger second half.
They said both their olive leaf product for reducing blood sugar levels, and their cardio-vascular product, have been well received. Apparently Olive Leaf products have previously been seen as just a cold & flu product so this gives them an opportunity to reduce the seasonality of olive leaf sales. CEO also mentioned they were working on a new olive leaf product and a new ingredient platform but wouldn't give any more detail. Because demand is strong they said growing supply will have an immediate impact on bottom line and they're focussing there. Their supply from their latest apiary acquisition is going to come on board shortly (didn't catch the date sorry).

Disc. hold CVT[/QUOT

Yes , they certainly talking the talk , lets hope they can walk the walk